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Summary
Background: Bacteremia is a frequent complication found in HIV-infected patients and is usually
associated with a poor prognosis. This study was undertaken to describe the bacterial pathogens
causing bacteremia in adult Thai HIV-infected patients, and hence to give guidance in the choice
of empirical antimicrobials.
Methods: Blood culture results at Srinagarind Hospital, Khon Kaen during the period January 1996
to December 2001 were retrospectively reviewed.
Results: In HIV-infected and HIV-uninfected patients, 172 and 4082 episodes of bacteremia
occurred, respectively. In HIV-infected patients, community-acquired and nosocomial bacteremia
were found in78.5%and21.5%, respectivelyandmostweremonomicrobial.Gram-negativebacteria
were the main pathogens isolated in both groups of bacteremia. Escherichia coli and methicillin-
resistant Staphylococcus aureus were more common pathogens causing nosocomial bacteremia in
HIV-infected patients, whereas Acinetobacter sppwere more common in HIV-uninfected patients.
Salmonella spp, especially Salmonella groups D and B, were the most common (62.2%) pathogen in
community-acquired bacteremia in HIV-infected patients whereas Escherichia coli was the most
common inHIV-uninfected patients. Only a few episodes of community-acquired bacteremia inHIV-
infected patients had identified sources. Co-trimoxazole resistance was common in community-
acquired bacteremia caused by Gram-negative bacilli in HIV-infected patients, with Salmonella
group B being more resistant to co-trimoxazole than Salmonella group D (statistically significant,
p < 0.001). However, resistance rates to ceftriaxone and ofloxacin were low.
Conclusions: Bacteremia in adult HIV-infected patients was usually caused by Gram-negative
bacilli in both community-acquired and nosocomial settings. Salmonella sppwas themost common
organism identified, especially Salmonella group B and D. Ceftriaxone or fluoroquinolones such as
ofloxacin or ciprofloxacin should be used as the initial empiric therapy for HIV-infected patients
with suspected bacteremia.
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Bacterial infections are not uncommon in HIV-infected
patients, both in community and in hospital settings.1—8
Bacteremia is a frequent complication found in HIV-infected
patients and is usually associated with a poor prognosis,3—8
responsible for the immediate cause of death in up to 32% of
HIV-infected patients, especially under particular conditions
(e.g., intravenous drug abuse, use of a central venous cathe-
ter (CVC), neutropenia, and a low CD4 T-cell count).5 Pre-
vious studies have shown variable distributions of organisms
causing bacteremia. The most common pathogens described
have been Staphylococcus aureus, Streptococcus pneumo-
niae, and especially Salmonella spp.1—8 Many factors may
affect the variation such as the proportion of intravenous
drug users in the study population, lifestyles, geographical
differences, neutropenia, and prior Pneumocystis carinii
pneumonia prophylaxis.
This study was undertaken to describe the bacterial
pathogens causing bacteremia in adult Thai HIV-infected
patients, and hence to give guidance in the choice of empiri-
cal antimicrobials.
Methods
Study design
The study was carried out at Srinagarind Hospital, a tertiary-
care teaching institution in the northeast of Thailand. This is
a 700-bed university teaching hospital affiliated with Khon
Kaen University that provides healthcare for a population of
nearly 1 500 000 inhabitants. There are approximately 32 000
admissions and 490 000 visits to the outpatient clinic each
year.
Microbiology laboratory logs were used to identify
patients with positive blood culture results during the
period January 1996 to December 2001. A list of patients
who had positive HIV serology and were more than 15 years
old was obtained from a computer-based search of diag-
nostic codes from the medical records section of the hos-
pital. Both comprehensive lists were matched and a list of
HIV-infected adult patients who had positive blood cultures
was obtained.
Medical records were retrospectively reviewed and only
patients who fitted the diagnostic criteria of true bacteremia
were selected. A variety of data were collected including
age, sex, exposure category of HIV infection, HIV clinical
status, place of acquisition of infection, source of infection,
concurrent opportunistic infections and clinical conditions as
listed in the surveillance case definition for AIDS established
by the Thai Center of Disease Control, other active diseases,
and in-hospital mortality.
Microbiologic methods
Blood was taken from a peripheral vein unless the patient had
a CVC, in which case blood was obtained from the catheter;
5—10 mL was inoculated into aerobic Bactalert vials. Blood
cultures were processed in the microbiology laboratory using
an automated Bactalert (Becton Dickinson Microbiology Sys-
tems, Maryland, USA) continuous monitoring system, using aseven-day protocol. Positive vials were sub-cultured and
isolates were identified by standard bacteriologic methods.
Susceptibility testing of the isolates was carried out using the
Kirby—Bauer disk diffusion method on Mueller—Hilton agar,
and zone diameters were interpreted according to the
National Committee for Clinical Laboratory Standards
(NCCLS). The antibiotic susceptibility was assessed as fol-
lows: Enterobacteriaceae (cefotaxime, co-trimoxazole, cef-
triaxone, ofloxacin, ampicillin), Pseudomonas aeruginosa,
Acinetobacter spp, Enterobacter spp (as Enterobacteriaceae
plus ceftazidime, piperacillin, imipenem, amikacin, genta-
micin, ciprofloxacin), staphylococci (co-trimoxazole, oxacil-
lin, cefazolin, gentamicin, and vancomycin, fosfomycin,
fusidic acid if oxacillin-resistant), Enterococcus spp (penicil-
lin, ampicillin, gentamicin, vancomycin).
Bacteremia or blood stream infection (BSI) was diagnosed
when a blood culture grew an organism with (secondary BSI)
or without (primary BSI) any obvious focus of sepsis. True
bacteremia was considered when one or more blood cultures
showed a recognized pathogen. Blood isolates of coagulase
negative staphylococci, Corynebacterium spp, Bacillus spp,
Clostridium spp, and any other potential contaminants were
excluded from our analysis if only one set of blood cultures
yielded the organism or the clinician did not initiate treat-
ment to cover it or did not consider it a true bacteremia.
Fungal or mycobacterial positive blood cultures were
excluded from this study.
Community-acquired bacteremia was defined if the first
positive blood culture was obtained before or within 48 hours
of hospitalization whereas nosocomial bacteremia was
defined if infections developed after 48 hours after hospita-
lization or within 14 days of previous admission.
The source of bacteremia was identified by the isolation
of the same pathogenic organism from both the source and
the blood. The following definitions were used to categorize
the source of the patients’ bacteremia. Pneumonia was
defined as the presence of an acute illness with respiratory
symptoms and an infiltrate on chest roentgenography. Cel-
lulitis required the physical finding of an erythema, tender-
ness, and warmth in a focal distribution. Phlebitis was
defined as an inflammation around a venous line site, a
positive line culture or a catheter in place at least 72 hours
and the absence of another source of bacteremia. Endocar-
ditis was defined as the demonstration of valvular vegeta-
tions on echocardiography, evidence of septic emboli or a
new murmur, and the absence of another source of bacter-
emia. A urinary tract infection required a positive urine
culture result and no other source of the bacteremia. Cathe-
ter-related blood stream infection (CRBSI) was diagnosed
when blood culture from a peripheral vein and CVC grew an
organism and the CVC tip with quantitative bacterial counts
>15 CFU (Maki method).
Statistical analysis
Data were entered and analyzed with SPSS Professional
Statistics, version 12.0 (SPSS Inc., Chicago, IL, USA). Compar-
ability between the groups was assessed by analysis with Chi-
square and Fisher’s exact tests for categorical variables and
Student’s t-test for continuous variables. Each mean was
expressed with its standard deviation. A p value of <0.05
was considered to be significant.
228 P. Mootsikapun
Figure 1 Algorithm of stratification of bacteremia in this study.Results
During the six-year study period, there were 8724 positive
blood cultures in Srinagarind Hospital of which 6521 were
considered as true bacteremia and were counted as 4254
episodes (Figure 1).
There were 147 HIV-infected patients who developed at
least one episode of bacteremia. Males comprised 71.4% of
the patients. Mean age at first episode of bacteremia was
31.65  8.69 years. All were in CDC (Centers for Disease
Control and Prevention) clinical category C. All but one,
who was homosexual, were heterosexual. A history of intra-
venous drug use was identified in only one case. None had
anti-retroviral treatment during the first episode of commu-
nity-acquired bacteremia.
A total of 172 bacteremic episodes occurred in the HIV-
infected patients, of which 135 (78.5%) and 37 (21.5%) were
community-acquired and nosocomial bacteremia, respec-
tively. The clinical features at admission of community-
acquired bacteremia were: fever without apparent focus
80 cases (59.6%), meningitis 11 cases (8.1%), pneumonia 13
cases (9.6%), peritonitis three cases (2.2%), infective diar-
rhea 23 cases (17.0%), urinary tract infection two cases
(1.5%), and skin and soft tissue infection three cases (2.2%).
Thirty-one HIV-infected patients had bacteremia during
acute treatment of opportunistic infections: cryptococcal
meningitis (9), tuberculosis (8), Pneumocystis carinii pneu-monia (PCP) (4), disseminated penicilliosis marneffei (4),
cytomegalovirus retinitis (3), cerebral toxoplasmosis (2),
and Rhodococcus equi lung abscess (1).
The CD4 cell count was determined in only 17 HIV-infected
patients as the test was not routinely done during the study
period. Themedian CD cell count was 17 cells/mm3 (range 0—
121). No viral load measurement was performed in any
patients.
Bacteriology
Table 1 lists the organisms found in community-acquired
bacteremic episodes and Table 2 shows those found in noso-
comial bacteremic episodes. The frequencies of pathogens
occurring in HIV-infected and HIV-uninfected patients were
compared. Monomicrobial bacteremia was more common
than polymicrobial bacteremia in both groups of patients
and in both categories of bacteremia. Polymicrobial bacter-
emia was more common in HIV-uninfected patients than in
HIV-infected patients with nosocomial bacteremia (Table 2).
Nineteen HIV-infected patients had multiple episodes of
bacteremia during the study period, all during different
hospitalizations. Ten, two, and one patient(s) had two,
three, and four episodes of community-acquired bacteremia,
respectively, of which one had three episodes of Salmonella
group B bacteremia. Three patients had multiple episodes of
nosocomial bacteremia.
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Table 1 Distribution of organisms isolated in community-acquired bacteremia
Organism HIV-infected n (%) (N = 135) HIV-uninfected n (%) (N = 2239) p value
Polymicrobial 3 (2.2) 92 (4.1)
Monomicrobial 132 (97.7) 2147 (95.9) 0.28
Salmonella group D 42 (31.1) 106 (4.7) <0.001
Salmonella group B 40 (29.6) 38 (1.7) <0.001
Other Salmonella spp 2 (1.5) 19 (0.8) 0.44
Enterobacter spp 11 (8.2) 80 (3.6) 0.007
Escherichia coli 7 (5.2) 413 (18.4) <0.001
Serratia spp 4 (3.0) 10 (0.4) <0.001
Burkholderia pseudomallei 4 (3.0) 210 (9.4) 0.01
Klebsiella pneumoniae 3 (2.2) 249 (11.1) <0.001
Other Klebsiella spp 0 (0.0) 25 (1.1) 0.22
Acinetobacter calcoaceticus biotype anitratus 1 (0.7) 0 (0.0) <0.001
Shigella sonnei 1 (0.7) 0 (0.0) <0.001
Aeromonas spp 0 (0.0) 60 (2.7) 0.05
Other Gram-negative bacilli 0 (0.0) 141 (6.3) 0.003
MSSAa 13 (9.6) 296 (13.2) 0.23
Streptococcus pyogenes 1 (0.7) 51 (2.3) 0.24
Streptococcus agalactiae 0 (0.0) 36 (1.6) 0.14
Streptococcus pneumoniae 0 (0.0) 48 (2.1) 0.08
Viridans streptococci 0 (0.0) 101 (4.5) 0.01
Enterococcus spp 1 (0.7) 110 (4.9) 0.02
Other Streptococcus spp 0 (0.0) 148 (6.6) 0.002
Rhodococcus equi 2 (1.5) 1 (0.1) <0.001
Nocardia spp 0 (0.0) 5 (0.2) 0.58
a MSSA, methicillin-sensitive Staphylococcus aureus.In community-acquired monomicrobial bacteremia,
Gram-negative bacteria (87.1%) were more common than
Gram-positive in HIV-infected patients but this was not so
pronounced in HIV-uninfected patients (62.9%) (Table 1).
Salmonella spp were the most common pathogen isolated
(63.6%) in HIV-infected patients whereas E. coli was the most
common in HIV-uninfected patients (19.2%) (Table 1). Among
Gram-negative pathogens, Salmonella spp, Enterobacter
spp, and Serratia spp were more common in HIV-infected
patients whereas Escherichia coli, Klebsiella pneumoniae,
and Burkholderia pseudomallei were more common in HIV-Table 2 Distribution of organisms isolated in nosocomial bactere
Organism(s) HIV-infected n (%) (N = 3
Polymicrobial 1 (2.7)
Monomicrobial 36 (97.3)
Escherichia coli 10 (27.0)
Klebsiella pneumoniae 8 (21.6)
Other Klebsiella spp 0 (0.0)
Pseudomonas aeruginosa 6 (16.2)
Enterobacter spp 3 (8.1)
Stenotrophomonas maltophilia 1 (2.7)
Acinetobacter spp 0 (0.0)
Other Gram-negative bacilli 0 (0.0)
MRSAa 6 (16.2)
Staphylococcus epidermidis 0 (0.0)
Enterococcus spp 2 (5.4)
Other Streptococcus spp 0 (0.0)
a MRSA, methicillin-resistant Staphylococcus aureus.uninfected patients. Most of the Salmonella bacteremia in
HIV-infected patients was identified as Salmonella group B
and Salmonella group D. Among Gram-positive pathogens,
Staphylococcus aureus was the most common. There were
only a few cases of the other gram-positive community-
acquired bacteremia in HIV-infected patients.
The sources of community-acquired bacteremia (the same
organism was isolated both in blood and at a specific foci)
were identified in only six HIV-infected patients and included
pneumonia in one, urinary tract infection in two, and skin and
soft tissue infections in three cases.mia
7) HIV-uninfected n (%) (N = 1843) p Value
281 (15.2)
1562 (84.8) 0.03
278 (15.1) 0.04
214 (11.6) 0.06
35 (1.9) 0.4
230 (12.5) 0.5
131 (7.1) 0.81
114 (6.2) 0.38
217 (11.8) 0.03
149 (8.1) 0.07
135 (7.3) 0.04
13 (0.7) 0.6
32 (1.7) 0.1
14 (0.8) 0.59
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Table 3 Frequencies of antibiotic resistance of common community-acquired pathogens in HIV-infected patients
Organisms Resistance rate (%)
Co-trimoxazole Ceftriaxone Ofloxacin
Salmonella group D (n = 43) 16 (37.2) 0 (0.0) 5 (11.6)
Salmonella group B (n = 41) 34 (82.9) 0 (0.0) 0 (0.0)
Enterobacter spp (n = 12) 6 (50.0) 1 (8.3) 3 (25.0)
Escherichia coli (n = 9) 8 (88.9) 1 (11.1) 2 (22.2)
Overall Gram-negative bacilli 72/119 (60.5) 8/115 (7.0) 13/104 (12.5)
MSSAa (n = 12) 2 (16.7) Not done Not done
a Methicillin-sensitive Staphylococcus aureus.Only 30 HIV-infected patients had co-trimoxazole for PCP
prophylaxis. All had co-trimoxazole-resistant community-
acquired bacteremia. The relationships of susceptibility to
co-trimoxazole, ceftriaxone, and ofloxacin and the commonly
found organisms causing community-acquired bacteremia in
HIV-infected patients are shown in Table 3. The resistance rate
to co-trimoxazole was very high in Gram-negative bacilli,
especially in Salmonella group B and E. coli. Salmonella group
B was more resistant to co-trimoxazole than Salmonella group
D (statistically significant, p < 0.001). Among Gram-negative
pathogens, there was a low resistance rate to ceftriaxone and
ofloxacin with the exception of E. coli.
For nosocomial bacteremia, the most common organisms
isolated were also Gram-negative bacteria, and E. coli, K.
pneumoniae, and P. aeruginosa were the most common
pathogens in both HIV-infected and HIV-uninfected patients.
Methicillin-resistant S. aureus and enterococci were themost
common Gram-positive bacteria. Escherichia coli and methi-
cillin-resistant Staphylococcus aureus were more common
pathogens causing nosocomial bacteremia in HIV-infected
patients, whereas Acinetobacter spp were more common
in HIV-uninfected patients.
Outcome
All of the HIV-infected patients who presented with sepsis at
Srinagarind Hospital would have received the empirical ther-
apy of intravenous ceftriaxone 2 g daily. If the patients
clinically improved, this would have been switched to oral
ofloxacin 400 mg daily and continued for a total course of 2—3
weeks. The in-hospital mortality of the HIV-infected patients
with community-acquired bacteremia was very low. Only one
HIV-infected patient who had community-acquired MSSA died
during admission. In 37 HIV-infected patients who had noso-
comial bacteremia, the in-hospital mortality rate was 69.6%,
which was higher than that for community-acquired bacter-
emia and statistically significant ( p < 0.05).
Discussion
Bacterial infections are common in HIV-infected patients
because of abnormalities in humoral, cellular, and mucosal
immunity. HIV-infected patients have an increased risk of
bacteremia during bacterial infections.1—3 Many studies have
demonstrated that the prevalence of bacteremia in HIV-
infected patients who have fever and are hospitalized ranges
from 5 to 28%.4—8 A report on the prevalence of bacteremia inThai HIV-infected patients gave a range of 20—30% each
year.9 The common sources of infections are pneumonia
and gastroenteritis but most of them are unknown. In this
study, the primary source of bacteremia in most cases could
not be identified, especially in Salmonella bacteremia.
In North America and European countries, Staphylococcus
species are the most common causes of bacterial infections
and bacteremia due to the high rate of intravenous drug use,
central venous catheters, and neutrophil defects. Gram-
negative bacteria are also common in HIV-infected patients,
especially non-typhoidal salmonella with the relative risk
being between 20 and 100 times that of the general popula-
tion. In this study, most of the monomicrobial bacteremia in
the HIV-infected patients was caused by Gram-negative
bacilli, found in 87.1% and 77.8% of community-acquired
and hospital-acquired bacteremia, respectively (Tables 1
and 2). Gram-positive bacteremia was much less frequently
found. This may be explained by the low prevalence of
intravenous drug use as a risk factor for transmission
(4.7%),10 and rare central catheter insertion and neutropenia
in the Thai HIV-infected population. Salmonella was identi-
fied in 62.2% of community-acquired bacteremia and Salmo-
nella groups D and B were the most common species. These
results are similar to those found in the study of Chierakul
et al.11 performed at a provincial hospital in the same region
as Srinagarind Hospital. However, Srifuengfung et al.9 sur-
veyed blood culture results of HIV-infected patients in a
hospital in the central region of Thailand and although
Salmonella and E. coli were revealed as the most common
pathogens, Salmonella group C was the most common. This
may result from different hygiene and environment. Non-
typhoidal salmonellosis has been associated with high mor-
tality and recrudescence in HIV-infected patients.12—14
In nosocomial bacteremia, Gram-negative bacteria were
more common than Gram-positive bacteria. All of the bac-
teremia was caused by multidrug-resistant organisms. These
results are similar to those of other reports.7,8
Althoughco-trimoxazole iswidelyusedasPneumocystis and
Toxoplasma prophylaxis, it may not prevent the occurrence of
bacterial infections and bacteremia.15 Co-trimoxazole resis-
tance may even lead to a higher incidence of bacteremia. The
co-trimoxazole resistance rate in the community-acquired
Gram-negative bacilli bacteremia in our study was 60.5%
(Table 3). Most of the Salmonella group B had resistance to
co-trimoxazole whereas those of Salmonella group D were
more sensitive. However, most of the community-acquired
Gram-negative bacilli in our datawere sensitive to ceftriaxone
and ofloxacin or ciprofloxacin. A similar sensitivity patternwas
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fore, we suggest that the antibiotic susceptibility pattern of
commonbacteremicpathogens inHIV-infectedpatients should
be determined. If a high co-trimoxazole resistance rate is
found, it should not be used as the empirical therapy in septic
HIV-infected patientswith suspected bacteremia. Ceftriaxone
orfluoroquinolones such as ofloxacinor ciprofloxacin should be
an appropriate empirical choice in this setting. In our hospital
practice, we usually use fluoroquinolones or ceftriaxone for
empirical therapyandchange the regimenaccording to return-
ing sensitivity patterns. This may explain the low in-hospital
mortality rate in this study.
Because non-typhoidal salmonella bacteremia in HIV-
infected patients has a high rate of mortality and recrudes-
cence,12—14 it is recommended that the antibiotics should be
continued for at least 4—6 weeks.16 However, this was found
in only one case in this study and only 2—3weeks of treatment
were given. This may be a benefit of treatment with fluor-
oquinolones as oral switching therapy because it is known
that ciprofloxacin can reduce carrier state and delay recru-
descence in enteric fever.
There have beenmany reports revealing a reduction in the
incidence and epidemiology of bacterial infections and bac-
teremia after introducing highly active antiretroviral therapy
(HAART) into the HIV population.17,18 In the study period,
there were few HIV-infected patients that could access
HAART. In Thailand after 2002, a National Antiretroviral Free
Access Program for patients with CD4 counts of less than 200
cells/mm3 was introduced. The incidence rate of bacteremia
has predictably decreased.
Conclusion
Bacteremia in adult HIV-infected patients was usually caused
by Gram-negative bacilli in both community-acquired and
nosocomial settings. Salmonella spp was the most common
organism identified, especially Salmonella group B and D. In
vitro data of susceptibility showed that Salmonella group B
was usually resistant to co-trimoxazole but sensitive to
ceftriaxone and fluoroquinolones. This should be kept in
mind when selecting empirical antibiotics for sepsis in HIV-
infected patients.
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